Build a computer model of each patient's cancer and body that simulates how different treatments would go, and prove in a proper trial that choosing treatment with the model helps.
Multimodal models combining genomics, pathology, imaging, pharmacokinetics and clinical history increasingly predict outcomes, but no digital twin has been validated as a decision tool in a randomised trial. The proposal is an open framework: standardised inputs, mechanistic plus learned components, calibration on federated real-world and trial data, and a series of randomised trials in which treatment selection assisted by the twin is compared with standard multidisciplinary decision-making, with regulators engaged on the evidence standard.
Shares How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals, Pathology & radiology foundation models, AI that is built but not validated or deployed, Digital pathology & AI.
Shares Patient-level multimodal foundation models for treatment selection, Pathology & radiology foundation models, AI that is built but not validated or deployed, Digital pathology & AI.
Shares Patient-level multimodal foundation models for treatment selection, Pathology & radiology foundation models, AI that is built but not validated or deployed, Digital pathology & AI.
Shares Patient-level multimodal foundation models for treatment selection, How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals, Pathology & radiology foundation models, AI that is built but not validated or deployed.
Shares Patient-level multimodal foundation models for treatment selection, Pathology & radiology foundation models, AI that is built but not validated or deployed, Digital pathology & AI.
Shares Patient-level multimodal foundation models for treatment selection, How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals, AI that is built but not validated or deployed.
Shares Patient-level multimodal foundation models for treatment selection, Pathology & radiology foundation models, AI that is built but not validated or deployed, Digital pathology & AI.
Shares How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals, AI that is built but not validated or deployed, Too many combinations to test.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/